The Dry Eye Syndrome Treatment Market To Be Servile Towards Persistence At The Rate Of 7% Between 2030

 Dry eye syndrome results in irritated and burning eyes due to lack of tear production and moisturization. Meibomian Gland Dysfunction has more prevalence among the geriatric population. The market consists of several products used in therapeutics, such as cyclosporine, topical corticosteroids, punctal plugs, omega supplements, and the especially popular artificial tears. Fast approval and launch of products used for dry eye treatment is expected to drive market growth in future.

Several key market players are focused on collaborative product development, innovation, and expansion of product portfolio. For instance, in October 2020, Santen Pharmaceutical and Orbis International announced their long-term collaboration for ten years to contribute toward the increasing burden of eye diseases in low- and middle-income countries.

Rapidly increasing number of eye care centers due to rising focus on primary eye care is expected to propel dry eye syndrome treatment market growth. Increasing number of LASIK surgeries, which is one of the major causes leading to dry eyes, is estimated to further drive market growth over the coming years.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/32300

Companies covered in Dry Eye Syndrome Treatment Market Report

  • Allergan Plc.
  • Novartis AG
  • Otsuka Pharmaceutical Co.,Ltd.
  • Santen Pharmaceutical Co Ltd.
  • Bausch Health Companies Inc.
  • Akorn, Inc.
  • Johnson & Johnson, Inc.
  • Thea Pharmaceuticals Limited
  • OASIS Medical
  • Altaire Pharmaceuticals Inc.
  • Boiron USA
  • Similasan Corporation
  • Scope Ophthalmics Ltd.
  • Reckitt Benckiser Group PLC
  • Medicom Healthcare Ltd
  • FDC Limited.
  • Lupin Limited
  • Jamjoom Pharmaceuticals Co.
  • Sentiss Pharma Private limited

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/32300

The global dry eye syndrome treatment market is estimated to be valued at over US$ 4.2 Bn in 2020, and is expected to exhibit an impressive CAGR of 7% over the forecast period (2020-2030).

Key Takeaways from Market Study

  • The artificial tears segment, by product, is estimated to generate the highest revenue share over the coming years, estimated to be valued at US$ 5 Bn by 2030, at an expected CAGR of over 7%.
  • COVID-19 has had a negative impact on the dry eye syndrome treatment market due to large-scale closures of manufacturing units and disruption in supply chain activities. Decreased hospital visits and focus on the pandemic further hurt market growth in 2020. However, long-term prospects look bright through 2030.
  • Among the prescriptions, Rx is expected to dominate the market with more than 70% revenue share, with increasing number of eye care centers and rising treatment adoption rate for dry eyes.
  • Among all distribution channels, retail pharmacies is the leading segment, followed by hospital pharmacies. Retail pharmacies are anticipated to grow at a CAGR of around 7% over the forecast period, owing to rise in the number of retail pharmacies and improving supply chain activities.
  • North America and Europe are leading regions in the global dry eye syndrome treatment market, with a revenue share of around 70%.
  • The market in the U.S. and Germany is projected to expand at a CAGR of around 7% through 2030.
  • The market in Japan is slated to progress at a steady CAGR of over 6% over the next ten years.

“Rising diagnosis and treatment adoption has led to increasing product innovation and development, contributing to market. Developing and under-developed countries with high prevalence of dry eye syndrome and lower product adoption will create several opportunities for leading market players,” says a Persistence Market Research analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/32300

Product Innovation & Development – Key Strategy for Market Players 

Approvals by the U.S. FDA for dry eye syndrome treatment products are expected to push the market toward high competition. Leading companies are focusing on advanced product development with high efficacy and ease of use. For instance, in June 2020, I-MED Pharma Inc. announced the launch of “I-DEFENCE”, an ointment for the moisturising and protection of the ocular surface, in Canada.

Key Participant Insights

The global market is set to broaden its scope over the forecast period, stimulated by high prevalence of dry eye syndrome, rising geriatric population, and increasing adoption of advanced dry eye syndrome treatment products that can be used for long-term care needs. Moreover, strategic collaborations and acquisitions by key manufacturers are leading to the expansion of the market.

Key market players covered in the study include Allergan Plc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Santen Pharmaceutical Co. Ltd., Bausch Health Companies, Inc., Akorn, Inc., Johnson & Johnson, Inc., Thea Pharmaceuticals Limited, OASIS Medical, Altaire Pharmaceutical Inc., Boison USA, Similasan Corporation, Scope Ophthalmic Ltd., Reckitt Benckiser Group Plc, Medicom Healthcare Ltd., FDC Limited, Lupin Limited, Jamjoom Pharmaceuticals Co., and Sentiss Pharma Private Limited, who are consolidating their positions through mergers, acquisitions and new product launches.

What else is in the report?

Persistence Market Research brings a comprehensive research report on forecast revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global dry eye syndrome treatment market is segmented in detail to cover every aspect of the market, and present a complete market intelligence approach to the reader. The study provides compelling insights on the basis of product (cyclosporine, topical corticosteroids, artificial tears, punctal plugs [removable and dissolvable], omega supplements, and others [osteoporosis and others), prescription (Rx, OTC, and medical devices), and distribution channel (hospital pharmacies, eye health clinics, retail pharmacies, and online pharmacies), across seven major regions of the world.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Comments

Post a Comment

Popular posts from this blog

A CAGR Of 15% Expected To Be Registered Between 2031 For Disinfection Robot Market

  According to a revised report published by Persistence Market Research, the global   disinfection robots market  valued at   US$ 1 Bn   in 2020, and is predicted to surge at a   CAGR of more than 15%   during the forecast period (2021–2031). Impact of the COVID-19 pandemic due to the spread of SARS-CoV-2 has tested the obtainability of traditional disinfectants, which has led to a spike in demand for disinfection robots from institutions and companies. These robots are deployed progressively as an artless solution for the instantaneous decontamination of all surfaces of common areas and rooms, and, as such, they seem an attractive alternative for reducing dependency on cleaning services. Presently, disinfection robots are not an alternative to hospital cleaning services, but can be a complementary solution. Get Sample Copy of this Report @  https://www.persistencemarketresearch.com/samples/22822 Various companies received FDA & CE appro...
Read more

Servo Motors Drives Market: Future Forecast Indicates Impressive Growth Rate 2019 – 2029

Image
  The global servo motors and drives market was valued at  ~ US$ 9 Bn in 2014,  and is expected to surpass  US$ 12 Bn  by the end of  2019 . The servo motors and drives market is expected to grow at a  CAGR of ~ 8% between 2019 and 2029 , and is estimated to reach a global value of  ~ US$ 28 Bn  by the end of  2029. Persistence Market Research released a new market study on the servo motors and drives market, which includes the global industry analysis  2014–2018  and forecast  2019–2029 . The report studies the global servo motors and drives market and offers an in-depth analysis for the next ten years. The report on the global servo motors and drives market contains vital macroeconomic and forecast factors that are estimated to drive the growth of the global servo motors and drives market. The report on the servo motors and drives market also discusses restraints that are expected to hamper the global market, a...
Read more

Increased Adoption of Virtual Desktop Infrastructure Market across End-Use Industries to Fuel Revenue Growth During the Forecast Period by 2030-Persistence Market Research

  As per findings of a new market research report by Persistence Market Research, the global   virtual desktop infrastructure market   reached a valuation of nearly   US$ 3.5   Bn in   2019 , and is anticipated to exhibit a CAGR of around   12%   during the forecast period of   2020  to   2030 . The adoption of BYOD allows employees to bring their own devices in the organization, which allows then to access company information and applications via virtual desktop infrastructure. With such a BYOD policy, both, employers and employees can avail benefits such as reliable data backup, cost savings, expanded mobility, increased productivity, and job satisfaction. Virtual desktop infrastructure helps secure the employee devices, as it supports a highly secure infrastructure. This system is like screen-scraping technology used with mainframe computers, where no actual data is delivered to the device, and all data remains in the data center...
Read more